Please Wait
Applying Filters...
menu
    • menu
    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-08-11

    Virtual Booth

    An Enquiry

    Menu

    Pridopidine

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Prilenia, Ferrer Give EU Update on Pridopidine in Huntington
    Prilenia, Ferrer Give EU Update on Pridopidine in Huntington

    25 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250725635763/en/Prilenia-and-Ferrer-Provide-Update-on-European-Regulatory-Process-for-Pridopidine-in-Huntingtons-Disease

    BUSINESSWIRE
    25 Jul 2025
    Share Share
    Ferrer collaboration with Prilenia for Pridopidine deal
    Ferrer collaboration with Prilenia for Pridopidine deal

    28 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250427034068/en/Ferrer-Enters-Into-a-Collaboration-and-License-Agreement-With-Prilenia-for-the-Commercialization-and-Co-Development-of-Pridopidine

    BUSINESSWIRE
    28 Apr 2025
    Share Share
    We Enter into Collab & License Deal With Prilenia For Pridopidine
    We Enter into Collab & License Deal With Prilenia For Pridopidine

    28 Apr 2025

    // PRESS RELEASE

    https://www.ferrer.com/en/Ferrer-enters-into-a-collaboration-and-license-agreement-with-Prilenia-for-the-commercialization-and-co-development-of-Pridopidine

    PRESS RELEASE
    28 Apr 2025
    Share Share
    Prilenia: Huntington's, ALS Pridopidine Data At AAN 2024
    Prilenia: Huntington's, ALS Pridopidine Data At AAN 2024

    12 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240412355764/en

    BUSINESSWIRE
    12 Apr 2024
    Share Share
    Prilenia Plans to Submit MAA in the EU for Pridopidine in Huntington’s Disease
    Prilenia Plans to Submit MAA in the EU for Pridopidine in Huntington’s Disease

    12 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240311060274/en

    BUSINESSWIRE
    12 Mar 2024
    Share Share
    Aural Speech Technology Signaled Slowing of Decline in ALS Patients’ Speech
    Aural Speech Technology Signaled Slowing of Decline in ALS Patients’ Speech

    24 Feb 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230223005772/en

    BUSINESSWIRE
    24 Feb 2023
    Share Share